drugset / Trial / NCT00846547
Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders
NaSingle-groupOpen-labelTreatment
Summary
The study objective is to explore the safety and tolerability of STX209 in subjects with Autism Spectrum Disorders and to obtain preliminary data on several measures of efficacy in treating irritability. We hypothesize that STX209 will be safe and well-tolerated.
Timeline
- Start
- 2009-02
- Primary completion
- 2010-06
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Arbaclofen | Small molecule | 1 mg | Oral |
| Subject | Arbaclofen | Small molecule | 10 mg | Oral |